Company Filing History:
Years Active: 1998
Title: David Camarero Torrecillas: Innovator in Therapeutic Human Albumin
Introduction
David Camarero Torrecillas is a notable inventor based in San Fausto de Camp-Centellas, Spain. He has made significant contributions to the field of therapeutic proteins, particularly in the development of human albumin with a low aluminium binding capacity. His work is crucial for improving the safety and efficacy of intravenous therapies.
Latest Patents
David holds a patent for a therapeutic human albumin that exhibits a very low capacity for aluminium absorption during storage in glass receptacles. The final composition of this albumin solution is designed to be stable and isotonic at concentrations of 5%, 20%, or 25% protein in an aqueous medium. Notably, the citrate content in the final albumin composition is equal to or less than 0.5 mM, and preferably less than 0.037 mM, making it suitable for intravenous administration.
Career Highlights
David is currently associated with Grupo Grifols, S.A., a leading global healthcare company specializing in plasma-derived medicines. His role at the company allows him to leverage his expertise in therapeutic proteins to advance medical treatments.
Collaborations
David collaborates with Pere Ristol Debart, contributing to innovative projects that aim to enhance therapeutic options for patients.
Conclusion
David Camarero Torrecillas is a prominent figure in the field of therapeutic human albumin, with a focus on improving patient safety through innovative solutions. His contributions are vital for the advancement of intravenous therapies.